menopause and glp 1 The GLP-1/GIP dual-receptor agonist tirzepatide led to at least 15% loss of total body fat in premenopausal, perimenopausal, postmenopausal women, but postmenopausal women taking menopausal hormone therapy had the greatest weight GLP-1 for Menopause Weight Loss

Must be used within the plan year or grace period

Glutathione for Mycotoxins Series of treatments Intravenous Glutathione is our main treatment for the management of mycotoxins (mold toxins) excreted from the body in urine testing Glutathione is central to mycotoxin detoxification and is necessary for people with impairment in their glutathione detoxification capacity It is done in a series of increasing doses, twice weekly over the course of 4 weeks

(p)NNS-Conjugated Chitosan Mediated IGF-1 and miR-140 Overexpression in Articular [PMID: 31016187] Laboratory literature summary: (p)NNS-Conjugated Chitosan Mediated IGF-1 and miR-140 Overexpression in Articular Chondrocytes Improves Cartilage Repair

Long COVID shares many features with ME/CFS, including persistent fatigue, cognitive impairment, and post-exertional malaise